YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Wall Street
Price Targets
Price Targets Summary
YiChang HEC ChangJiang Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for YiChang HEC ChangJiang Pharmaceutical Co Ltd is 12.85 HKD with a low forecast of 12.73 HKD and a high forecast of 13.23 HKD.
Revenue
Forecast
Revenue Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's revenue is 19%. The projected CAGR for the next 2 years is 19%.
Operating Income
Forecast
Operating Income Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's operating income is 7%. The projected CAGR for the next 3 years is 41%.
Net Income
Forecast
Net Income Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's net income is 3%. The projected CAGR for the next 2 years is 86%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's stock price target?
Price Target
12.85
HKD
According to Wall Street analysts, the average 1-year price target for YiChang HEC ChangJiang Pharmaceutical Co Ltd is 12.85 HKD with a low forecast of 12.73 HKD and a high forecast of 13.23 HKD.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
19%
For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's revenue is 19%. The projected CAGR for the next 2 years is 19%.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
41%
For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's operating income is 7%. The projected CAGR for the next 3 years is 41%.
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
86%
For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's net income is 3%. The projected CAGR for the next 2 years is 86%.